Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 626 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, dasatinib, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Dasatinib, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 6 mg/1; Deflazacort 36 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Riociguat 1 mg/1; Riociguat .5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1; Fluorescein sodium 100 mg/mL
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Solution, Capsule, Injection, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Kinase Inhibitor, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Calcitonin, Phosphate Binder, Oxidation-Reduction Agent, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 166 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Lubiprostone | Lubiprostone 24 ug/1 | CapsuleOral | 70710-1642 | 70710-1642-0170710-1642-06 | — |
| Buspirone hydrochloride | Buspirone hydrochloride 7.5 mg/1 | TabletOral | 68382-623 | 68382-0623-0168382-0623-0568382-0623-10+1 more | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 70710-1030 | 70710-1030-0170710-1030-07 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 70710-1034 | 70710-1034-0170710-1034-08 | — |
| Arsenic trioxide | Arsenic trioxide 1 mg/mL | Injection, SolutionIntravenous | 70710-1895 | 70710-1895-06 | — |
| Arsenic trioxide | Arsenic trioxide 2 mg/mL | Injection, SolutionIntravenous | 70710-1896 | 70710-1896-06 | — |
| sirolimus | Sirolimus 2 mg/1 | Tablet, Film coatedOral | 68382-352 | 68382-0352-0168382-0352-77 | — |
| sirolimus | Sirolimus 1 mg/1 | Tablet, Film coatedOral | 68382-351 | 68382-0351-0168382-0351-77 | — |
| Teriflunomide | Teriflunomide 7 mg/1 | Tablet, Film coatedOral | 70710-1114 | 70710-1114-0370710-1114-08 | — |
| Teriflunomide | Teriflunomide 14 mg/1 | Tablet, Film coatedOral | 70710-1115 | 70710-1115-0370710-1115-08 | — |
| amiodarone hydrochloride | Amiodarone hydrochloride 100 mg/1 | TabletOral | 68382-297 | 68382-0297-06 | — |
| amiodarone hydrochloride | Amiodarone hydrochloride 400 mg/1 | TabletOral | 68382-298 | 68382-0298-06 | — |
| Haloperidol | Haloperidol 1 mg/1 | TabletOral | 68382-408 | 68382-0408-0168382-0408-1068382-0408-77 | — |
| Haloperidol | Haloperidol .5 mg/1 | TabletOral | 68382-407 | 68382-0407-0168382-0407-1068382-0407-77 | — |
| Haloperidol | Haloperidol 2 mg/1 | TabletOral | 68382-409 | 68382-0409-0168382-0409-1068382-0409-77 | — |
| Lurasidone hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, CoatedOral | 68382-859 | 68382-0859-0168382-0859-0568382-0859-06+2 more | — |
| Lurasidone hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, CoatedOral | 68382-967 | 68382-0967-0168382-0967-0568382-0967-06+2 more | — |
| Lurasidone hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, CoatedOral | 68382-965 | 68382-0965-0168382-0965-0568382-0965-06+2 more | — |
| Lurasidone hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, CoatedOral | 68382-966 | 68382-0966-0168382-0966-0568382-0966-06+2 more | — |
| Lurasidone hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, CoatedOral | 68382-968 | 68382-0968-0168382-0968-0568382-0968-06+2 more | — |
| Topiramate | Topiramate 50 mg/1 | Capsule, Extended releaseOral | 70710-1040 | 70710-1040-0370710-1040-09 | — |
| Topiramate | Topiramate 25 mg/1 | Capsule, Extended releaseOral | 70710-1039 | 70710-1039-0370710-1039-09 | — |
| Topiramate | Topiramate 100 mg/1 | Capsule, Extended releaseOral | 70710-1041 | 70710-1041-0370710-1041-09 | — |
| Topiramate | Topiramate 150 mg/1 | Capsule, Extended releaseOral | 70710-1042 | 70710-1042-0370710-1042-09 | — |
| Topiramate | Topiramate 200 mg/1 | Capsule, Extended releaseOral | 70710-1043 | 70710-1043-0370710-1043-09 | — |
| Triazolam | Triazolam .25 mg/1 | TabletOral | 70710-1289 | 70710-1289-0170710-1289-0570710-1289-08 | — |
| Triazolam | Triazolam .125 mg/1 | TabletOral | 70710-1521 | 70710-1521-0170710-1521-0570710-1521-08 | — |
| ketorolac tromethamine | Ketorolac tromethamine 10 mg/1 | Tablet, Film coatedOral | 70710-1710 | 70710-1710-01 | — |
| Lacosamide | Lacosamide 10 mg/mL | InjectionIntravenous | 70710-1886 | 70710-1886-06 | — |
| Sildenafil Citrate | Sildenafil citrate 10 mg/mL | Powder, For suspensionOral | 70710-1716 | 70710-1716-0470710-1716-05 | — |
| Fingolimod | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | 68382-912 | 68382-0912-0168382-0912-0668382-0912-16+2 more | — |
| Roflumilast | Roflumilast 500 ug/1 | TabletOral | 68382-969 | 68382-0969-0668382-0969-16 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 70710-1031 | 70710-1031-0170710-1031-07 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 70710-1032 | 70710-1032-0170710-1032-07 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 70710-1033 | 70710-1033-0170710-1033-08 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 70710-1035 | 70710-1035-0170710-1035-08 | — |
| Venlafaxine | Venlafaxine hydrochloride 37.5 mg/1 | Tablet, Extended releaseOral | 70710-1348 | 70710-1348-0170710-1348-0370710-1348-09 | — |
| Venlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | 70710-1349 | 70710-1349-0170710-1349-0370710-1349-09 | — |
| Venlafaxine | Venlafaxine hydrochloride 150 mg/1 | Tablet, Extended releaseOral | 70710-1350 | 70710-1350-0170710-1350-0370710-1350-09 | — |
| Venlafaxine | Venlafaxine hydrochloride 225 mg/1 | Tablet, Extended releaseOral | 70710-1352 | 70710-1352-0170710-1352-0370710-1352-09 | — |
| Prochlorperazine Maleate | Prochlorperazine maleate 5 mg/1 | TabletOral | 70710-1667 | 70710-1667-01 | — |
| Prochlorperazine Maleate | Prochlorperazine maleate 10 mg/1 | TabletOral | 70710-1668 | 70710-1668-01 | — |
| Lacosamide | Lacosamide 10 mg/mL | InjectionIntravenous | 70710-1359 | 70710-1359-06 | — |
| Nelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 70710-1839 | 70710-1839-0170710-1839-08 | — |
| Famotidine | Famotidine 40 mg/1 | Tablet, Film coatedOral | 70710-1684 | 70710-1684-0070710-1684-0170710-1684-03+2 more | — |
| Famotidine | Famotidine 20 mg/1 | Tablet, Film coatedOral | 70710-1683 | 70710-1683-0070710-1683-0170710-1683-03+2 more | — |
| pemetrexedpemetrexed disodium | Pemetrexed disodium 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70710-1654 | 70710-1654-01 | — |
| pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70710-1655 | 70710-1655-01 | — |
| pemetrexedpemetrexed disodium | Pemetrexed disodium 1000 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70710-1674 | 70710-1674-01 | — |
| Diclofenac Potassiumdiclofenac potassium tablets | Diclofenac potassium 50 mg/1 | Tablet, Film coatedOral | 70710-1832 | 70710-1832-0070710-1832-0170710-1832-05 | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.